Related Experiment Videos
Von Willebrand factor in Behçet's syndrome
The Journal of Rheumatology
|April 1, 1987
Summary
Behçet's syndrome patients with vascular disease show elevated von Willebrand factor and Factor VIII antigen levels. These findings suggest a link between these markers and vascular complications in Behçet's syndrome.
Area of Science:
- Vascular Medicine
- Rheumatology
- Hematology
Background:
- Behçet's syndrome is a complex systemic vasculitis.
- Vascular disease is a serious complication of Behçet's syndrome.
- Endothelial dysfunction may play a role in Behçet's syndrome pathogenesis.
Purpose of the Study:
- To investigate plasma levels of von Willebrand factor (vWF) and Factor VIII related antigen (FVIII:RA) in patients with Behçet's syndrome.
- To compare these levels between patients with and without vascular involvement.
- To assess levels in relation to healthy and diseased controls.
Main Methods:
- Plasma samples were collected from patients with Behçet's syndrome (with and without vascular disease) and control groups.
- Levels of vWF and FVIII:RA were measured using specific immunoassays.
- Statistical analysis was performed to compare group differences.
Main Results:
- Elevated plasma vWF and FVIII:RA levels were observed in patients with Behçet's syndrome and vascular disease compared to those without vascular involvement.
- Patients with Behçet's syndrome and vascular disease had higher levels than healthy controls.
- Diseased controls, particularly those with systemic sclerosis, exhibited even higher FVIII:RA levels.
Conclusions:
- Elevated vWF and FVIII:RA may serve as biomarkers for vascular disease in Behçet's syndrome.
- These findings support the role of endothelial activation and coagulation abnormalities in the vascular complications of Behçet's syndrome.
- Further research is warranted to explore the therapeutic implications of targeting these hemostatic factors.